This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

J&J Recall Slideshow: The Recalls of 2011 & 2010

(J&J recall slideshow updated with company's latest medicine recall)

NEW YORK ( TheStreet) -- Medicine recalls that greatly defined Johnson & Johnson (JNJ - Get Report) last year continue to pester the company in 2011.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Most recently, J&J's McNeil Consumer Healthcare division said it was recalling certain lots of Tylenol 8 Hour, Tylenol Arthritis Pain and Tylenol upper respiratory products as a precautionary measure. The unit said it was also recalling certain lots of Benadryl, Sudafed and Sinutab products for the same reason. In addition, the division was recalling lots of Rolaids Multi-Symptom Berry Tablets.





It could almost be said that recalls defined consumer giant J&J in 2010, as its McNeil Consumer Healthcare division recalled tens of millions of packages of over-the-counter medicines that year, and the parent faced criminal investigation by the U.S. Justice Department as federal regulators became alarmed.

In turn, as the reputation of one of the world's most trusted names in consumer products became tarnished, shares of the company fell about 4% over the year, under-performing the S&P 500, which rose about 13% over the same time period. OTC drugs weren't the only products recalled by J&J in 2010; products from contact lenses to hip replacement products were also recalled.

TheStreet has compiled photos of major over-the-counter product recalls by J&J, creating a gallery that serves as a portrayal of J&J's yearlong market debacle last year -- and any other possible debacles in 2011. Read on for more ...

1 of 20

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
JNJ $101.35 -1.04%
AAPL $132.54 0.88%
GOOG $540.11 -0.44%
FB $80.54 0.07%
TSLA $247.73 0.86%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs